Top 27 Encodia investors
The most complete profiles first. Showing 27 of 27.
Carol SuhVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
David CruikshankVerified
Venture Capital, Investor · United States
Series BHealth CareLife ScienceBiotechnologyHardwarePortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Krishna YeshwantVerified
Venture Capital, Corporate Venture Capital, Investor · United States
Series BHealth CareTelecommunicationsHospitalsE-commercePortfolio: Pixie, Dialpad, Science 37, Synack and 90 more
Verified email available
Sean KendallVerified
Venture Capital, Private Equity Firm, Investor · United Kingdom
Series BHealth CareEnterprise SoftwareEnergyChemicalPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Victor TongVerified
Venture Capital, Private Equity Firm · United States
Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Verified email available
Claire ChinVerified
Venture Capital · China
Health CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Verified email available
Julie SunderlandVerified
Venture Capital · United States
Health CareGeneticsWomen FoundedChemicalPortfolio: Denali Therapeutics, Compass Therapeutics, Aledade, Verve Therapeutics and 12 more
Verified email available
Karim FarisVerified
Venture Capital, Corporate Venture Capital · United States
Health CareTelecommunicationsE-commerceConsumer GoodsPortfolio: Pixie, Dialpad, Science 37, Synack and 87 more
Verified email available
Mark McDonnellVerified
Venture Capital · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Qiang XuVerified
Venture Capital · China
Health CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Verified email available
Shaan GandhiVerified
Venture Capital · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Verified email available
Tom BrennanVerified
Venture Capital, Private Equity Firm · United States
Health CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Verified email available
Wei XuVerified
Venture Capital · China
Health CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Verified email available
Connor McDermott
Venture Capital, Investor · United States
SeedHealth CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Corey Ritter
Venture Capital, Investor · United States
Series BHealth CareLife ScienceRoboticsManufacturingPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Dan Zabrowski
Venture Capital, Private Equity Firm · United States
Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Contact details available
Fang Yang
Venture Capital, Private Equity Firm · China
Early Stage VentureHealth CareInvestment ManagementChemicalLife SciencePortfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Contact details available
Nick Pliam
Venture Capital, Private Equity Firm · United States
Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Contact details available
Nilay Thakar
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 65 more
Contact details available
Sharon Kedar, CFA
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Steve Gillis
Venture Capital, Private Equity Firm, Investor · United States
Series BHealth CareEnterprise SoftwareLife ScienceInformation Technology (IT)Portfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 68 more
Contact details available
Weizhi (Aaron) Li
Venture Capital, Private Equity Firm · China
Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Contact details available
Y. Katherine Xu
Venture Capital, Private Equity Firm · United States
Early Stage VentureHealth CareChemicalLife ScienceArtificial Intelligence (AI)Portfolio: LevitasBio, ARMO BioSciences, Mammoth Biosciences, Cue and 29 more
Contact details available
Mike Rubin, MD, PhD, CFA
Venture Capital, Private Equity Firm · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Patrick Smerkers
Venture Capital, Private Equity Firm · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
Robert Nelsen
Venture Capital, Investor · United States
Health CareLife ScienceBiotechnologyHealth DiagnosticsPortfolio: KSQ Therapeutics, OncoResponse, Remix Therapeutics, LifeMine Therapeutics and 78 more
Contact details available
Samantha Shalom
Venture Capital · United States
Health CareHospitalsAlternative MedicineWomen FoundedPortfolio: Vigil Neuroscience, Deep Lens, Farcast, Nanoview Biosciences and 30 more
Contact details available
By investment stage
By location
Related industries
Most-backed portfolio companies
Frequently asked questions
How many Encodia investors are on Angel Roster?
Angel Roster lists 27 Encodia investors. 13 of them (48%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (27), Private Equity Firms (13) and Corporate Venture Capital Firms (2). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do Encodia investors invest in?
Among those that list a stage, the most common are Series B (7), Early Stage Venture (6) and Seed (2).
Where are Encodia investors based?
Most are based in the United States (21), China (5) and the United Kingdom (1).
Which companies have Encodia investors backed?
The most-backed portfolio companies among them are Omniome (19), Mindstrong (18), Vizgen (15), Ultivue (15) and Verve Therapeutics (12).
How do I contact Encodia investors?
Create a free Angel Roster account to search and filter all 27, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.